Results 41 to 50 of about 1,145 (113)

Atazanavir Resensitizes Candida auris to Azoles. [PDF]

Antimicrob Agents Chemother, 2023
Elgammal Y, Salama EA, Seleem MN.
europepmc   +1 more source

Prevalence and correlates of hyperbilirubinemia among people living with HIV (PLHIV) receiving atazanavir boosted with ritonavir (ATV/r). [PDF]

BMC Gastroenterol
Farrokhi H, Shahmohamadi E, Pashaei A, Emadi Koochak H, Nooralioghli Parikhani S, Fathi Amrollah M, Mirzapour P, Dehghan Manshadi SA, SeyedAlinaghi S, Hackett D.   +9 more
europepmc   +1 more source

Model-based evaluation of the interaction between ritonavir-boosted atazanavir and rifampicin in Ugandan adults with HIV. [PDF]

Br J Clin Pharmacol
Kengo A, Resendiz-Galvan JE, Najjemba L, Mugerwa H, De Nicolò A, D'Avolio A, Atoyebi S, Wiesner L, Svensson EM, Waitt C, Denti P.   +10 more
europepmc   +1 more source

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV. [PDF]

Antimicrob Agents Chemother
Tsirizani L, Waalewijn H, Szubert A, Mulenga V, Chabala C, Bwakura-Dangarembizi M, Chitsamatanga M, Rutebarika DA, Musiime V, Kasozi M, Lugemwa A, McIlleron HM, Burger DM, Gibb DM, Colbers A, Denti P, Wasmann RE, CHAPAS-4 trial team.   +17 more
europepmc   +1 more source

Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review. [PDF]

Front Pharmacol
Spanakis M, Alexakis K, Ioannou P.
europepmc   +1 more source

Atazanavir-Loaded Crosslinked Gamma-Cyclodextrin Nanoparticles to Improve Solubility and Dissolution Characteristics. [PDF]

Turk J Pharm Sci, 2022
Dhabliya D, Khan SAQ, Umate M, Raut B, Singhavi D.   +4 more
europepmc   +1 more source

Brief Report: Prenatal Antiretroviral Exposure and Concomitant Neurodevelopmental Problems Among 5-Year-Old Children Who Are HIV-Exposed and Uninfected. [PDF]

J Acquir Immune Defic Syndr
Yao TJ, Zhang J, Malee K, Smith R, Rice ML, Redmond SM, Williams PL, Pediatric HIV/AIDS Cohort Study (PHACS).   +7 more
europepmc   +1 more source

Atazanavir-induced unconjugated hyperbilirubinemia prevents vascular hyporeactivity during experimental human endotoxemia. [PDF]

Front Immunol, 2023
Dorresteijn MJ, Dekker D, Zwaag J, Heemskerk S, Roelofs HMJ, Smits P, van der Hoeven JG, Wagener FADTG, Pickkers P.   +8 more
europepmc   +1 more source

Identification of Malaria-Selective Proteasome β5 Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation. [PDF]

Int J Mol Sci
Yasir M, Park J, Han ET, Han JH, Park WS, Chun W.   +5 more
europepmc   +1 more source

Using the Simcyp R Package for PBPK Simulation Workflows With the Simcyp Simulator. [PDF]

CPT Pharmacometrics Syst Pharmacol
Onasanwo AM, Mittapelly N, Shireman L, Vinden B, McNally K, Craig J, Bois FY.   +6 more
europepmc   +1 more source